Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Srdjan Petkovic
Observed name:
S Petkovic
Institutions:
Friedrich-Alexander-Universität Erlangen-Nürnberg,
Universitätsklinikum Erlangen
Observed institutions:
Friedrich-Alexander-Universität Erlangen-Nürnberg,
Universitätsklinikum Erlangen
ORCID:
0000-0002-2328-5251
Observed ORCID:
0000-0002-2328-5251
OpenAlex ID:
A5020350085
Targeted inhibition of protein synthesis renders cancer cells vulnerable to apoptosis by unfolded protein response
2023
·
Franziska Gsottberger
, Christina Meier
, et al.
·
Cell Death and Disease
·
17
PDF
Large B-cell lymphoma imprints a dysfunctional immune phenotype that persists years after treatment
2025
·
Richard J. Pelzl
, Giulia Benintende
, et al.
·
Blood
·
14
PDF
Human CD22-Transgenic, Primary Murine Lymphoma Challenges Immunotherapies in Organ-Specific Tumor Microenvironments
2021
·
Franziska Gsottberger
, Carolin Brandl
, et al.
·
International Journal of Molecular Sciences
·
4
PDF
10.03 Long lasting alterations of the immunophenotype and cytokine signature of DLBCL survivors results in persisting immune dysfunction
2024
·
G Benintende
, R Pelzl
, et al.
·
Journal for ImmunoTherapy of Cancer
·
1
PDF
Correction: Novel PE-DT-fusion toxin enhances internalization and target-dependently restores the cytotoxicity of recombinant immunotoxins
2026
·
Claudia Fischer
, Kerstin Wendland
, et al.
·
Frontiers in Pharmacology
PDF
Novel PE‐DT-fusion toxin enhances internalization and target-dependently restores the cytotoxicity of recombinant immunotoxins
2026
·
Claudia Fischer
, Kerstin Wendland
, et al.
·
Frontiers in Pharmacology
PDF
P-08.06 Optimizing promoter systems to enhance cytokine response in CAR T cells for tumor therapy
2025
·
L Steger
, F Gsottberger
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
P12.08 Targeting tumor-reduced drug accessibility to counteract organ-specific resistance to anti-CD22 immunotoxins
2024
·
F Gsottberger
, K Wendland
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
Alterations of Immune Cells By Large B Cell Lymphoma Persist Years after Achieving Complete Remission and Correlate with Impaired Adaptive Immunity
2022
·
Richard Pelzl
, Sabrina Kübel
, et al.
·
Blood
Block of Counter-Regulation By Inhibition of Protein Synthesis Sensitizes Cancer Cells to IRE1α-Mediated Apoptosis Following Unfolded Protein Response
2022
·
Franziska Gsottberger
, Christina Meier
, et al.
·
Blood
P03.20 A murine, myc-driven lymphoma model expressing human CD22 enables testing of targeted therapies and their effects on tumor immune microenvironment
2020
·
F Gsottberger
, C Brandl
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
P09.14 Blocking counterregulation of unfolded protein response by targeted protein synthesis inhibition produces highly synergistic cell death in several cancer entities
2020
·
F Gsottberger
, C Meier
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
Show more works
View as search
Works count:
12
Citation count:
36
H-index:
3
I10-index:
2
Year
Topic
Type